Submit Deal

INOZYME PHARMA

HQ - Boston

Summary

Inozyme is a clinical-stage biopharmaceutical company with approximately 50 employees in Boston.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 203 M

Avg. Deal Size£ 203 M

Market Context

Senior Management

Douglas A. Treco
CEO and Chairman
Stefan Riley
Senior Director of IR and Corporate Communications

Sort

centerview partners

HQ - New York

financial advisors (1)

1 Shared Deal

1 For

£ 203 M

Total Value

goodwin procter

HQ - Boston

legal advisors (1)

1 Shared Deal

1 For

£ 203 M

Total Value

biongage communications

pr advisors (1)

1 Shared Deal

1 For

£ 203 M

Total Value

skadden arps slate meagher & flom

HQ - New York

legal advisors to financial advisors (1)

1 Shared Deal

1 For

£ 203 M

Total Value

goldman sachs

HQ - New York

financial advisors (1)

1 Shared Deal

1 Opposite

£ 203 M

Total Value

cooley

HQ - Palo Alto

legal advisors (1)

1 Shared Deal

1 Opposite

£ 203 M

Total Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy